SCHEMBL25080907

SCHEMBL25080907

CC(C)(C)OC(=O)NCC1CCN(c2cccc(C(F)(F)F)c2)C1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.54
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
ALOX15 P16050 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ACACB O00763 8/20 0.49
SUV39H2 Q9H5I1 1/20 0.49
ACACA Q13085 6/20 0.48
CKS1B P61024 1/20 0.47
SKP1 P63208 1/20 0.47
SKP2 Q13309 1/20 0.47
NAMPT P43490 1/20 0.46
DRD2 P14416 1/20 0.46
POLB P06746 2/20 0.45
RORC P51449 1/20 0.45
CHRM4 P08173 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3711639 0.94 CKS1B (0.51) NOTUMACACBACACACKS1BSKP1
SCHEMBL15728295 0.87 TRPA1 (0.54) NOTUMKDM4EALDH1A1GAAMAPT
SCHEMBL10230212 0.85 CKS1B (0.59) KDM4EALDH1A1MAPTTDP1ACACB
SCHEMBL10230218 0.85 CKS1B (0.59) KDM4EALDH1A1MAPTTDP1ACACB
SCHEMBL30194577 0.83 NOTUM (0.53) NOTUMACACBSUV39H2ACACACKS1B
SCHEMBL22499987 0.82 NOTUM (0.57) NOTUMMAPTACACBSUV39H2POLB
SCHEMBL29689683 0.82 NOTUM (0.57) NOTUMMAPTACACBSUV39H2POLB
SCHEMBL10232155 0.81 TRPA1 (0.55) NOTUMSUV39H2CKS1BSKP1SKP2
SCHEMBL20063897 0.81 NOTUM (0.55) NOTUMGAAMAPTACACBPOLB
SCHEMBL948774 0.81 CKS1B (0.52) NOTUMKDM4EACACBACACACKS1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145598-A1 ACID CERAMIDASE INHIBITORS AND USES THEREOF UNIV CALIFORNIA (US) 2025-05-08 US disclosed
EP-4387617-A1 ACID CERAMIDASE INHIBITORS AND USES THEREOF The Regents of the University of California (US) 2024-06-26 EP disclosed
WO-2023023156-A1 ACID CERAMIDASE INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-02-23 WO disclosed
WO-2023023156-A1 ACID CERAMIDASE INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250145598-A1 ACID CERAMIDASE INHIBITORS AND USES THEREOF ASAH2, ASAH1, ACER2 NOTUM 317/4885KDM4E 3664/4885ALDH1A1 650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.